Investigates SMS2 pathway impairment in female lupus-prone mice, suggesting a role in disease susceptibility.
Introduction Systemic Lupus Erythematosus (SLE) is an antibody-mediated autoimmune disease with a striking female predominance. However, the mechanisms underlying this female bias remain poorly understood. Germinal Center (GC) B cell tolerance, a critical self-protective process that eliminates spontaneously generated autoreactive B cells, is essential for preventing SLE. However, whether impairment of GC B cell tolerance is sex-specific remains unclear. We previously identified the sphingomyelin synthetase 2 (SMS2)/protein kinase C δ (PKCδ) pathway as a critical regulator of GC B cell tolerance in mice, and that this pathway is impaired in lupus patients. Here, we investigated whether this impairment is specific to females using a lupus-prone mouse model. Methods Lupus prone NZBWF1 mice were used as the female bias of disease incidence is similar to that seen in humans. C57BL/6 mice were used as non-autoimmune controls. Untouched GC B cells and naïve B cells were isolated from male and female NZBWF1 mice for RT-PCR analysis of Sgms2 mRNA levels. In addition, GC and non-GC B cell SMS2 protein levels in male and female NZBWF1 mice were analyzed by flow cytometry. To understand the significance of reduced GC B cell SMS2 in lupus development, female NZBWF1 mice were treated with 2OHOA, a SMS activator, to test whether activation of the SMS2/PKCδ tolerance pathway could alleviate lupus pathogenesis. Results RT-PCR revealed that Sgms2 mRNA was significantly reduced in female NZBWF1 GC B cells when compared to males, but not in female C57BL/6 mice. Flow cytometry analysis also revealed a significant reduction in GC B cell SMS2 protein levels in female NZBWF1 mice compared to males. Activation of the SMS2/PKCδ tolerance pathway with 2OHOA significantly alleviated lupus pathogenesis in female NZBWF1 mice Conclusion These findings support that loss of GC B cell SMS2 expression is a female-specific deficit in SLE, which likely contributes to female bias in lupus.
No takes yet. Share an insight, caveat, or question.
Shai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: